Abstract: The present disclosure relates to the technical field of non-destructive detecting of residual stress, and in particular to a non-destructive detecting device for component residual stress gradient.

Abstract: The present invention relates to a series of 2,6-dioxaspiro [4,5] decane derivatives and applications thereof in preparation of opiate receptor ? agonist related drugs; and in particular relates to the derivative compounds shown in formula (I), tautomers thereof or pharmaceutically acceptable compositions thereof.

Abstract: Disclosed are an angiotensin II receptor 2 (AT2R) antagonist salt form and crystalline form, a preparation method therefor, and an application of the salt form and crystalline form in preparing a drug which treats chronic pain.

Abstract: The present invention relates to a compound shown in formula (II) or a pharmaceutically acceptable salt thereof and an application of the same in preparing a drug for treating a disease related to angiotensin II receptor type 2 (AT2R).

Abstract: The present invention relates to a crystal form and an amorphous form of dezocine analogue hydrochloride, and in particularly, to a crystal form of a compound represented by formula (I) and an amorphous form of a compound represented by formula (II). An X-ray powder diffraction spectrum of the crystal form comprises characteristic peaks at 2? values of 13.1°±0.2°, 16.8±0.2°, and 18.5±0.2°, and an X-ray powder diffraction spectrum of the amorphous form is shown in FIG. 1.

Abstract: The present invention relates to a class of TrkA inhibitors and an application thereof in the preparation of a drug for the treatment of diseases associated with TrkA. The present invention specifically discloses compounds represented by formula (I) and formula (II), tautomer thereof or pharmaceutically acceptable salts thereof.

Abstract: The present disclosure relates to the technical field of non-destructive detecting of residual stress, and in particular to a non-destructive detecting device for component residual stress gradient.

Abstract: A lifting container power generating device using a flexible guidance system includes a power source section, a power transmission section and an electrical section. The power source section includes a slide recess base electrically connected to a top portion of a flexible lifting container. A body is connected to the slide recess base through a linear bearing. A fixed roller and a sliding roller on the body are symmetrically disposed at two sides of a guide wire rope. Under the combined action of a preloaded spring and a tension spring, the fixed roller and the sliding roller jointly press tightly against the guide wire rope. The power transmission section includes an electromagnetic clutch axially connected to the fixed roller, and an electromagnetic clutch pulley connected to a power generator pulley via a V-belt. The power source section includes an electrical cabinet connected to the electromagnetic clutch, a power generator and a battery of the flexible lifting container.

Abstract: Disclosed are a sustained release suspension containing dezocine analogue ester and a preparation method therefor. According to the present invention, an injectable oily auxiliary material which may pharmaceutically serve as a sustained-release depot and an excipient are selected, and micronization technology is used jointly with high pressure homogenization technology and an anti-solvent technique to prepare an injectable long-acting suspension. The main components of the suspension are a compound represented by formula (I), the injectable oil, and the like.

Abstract: The present invention relates to a series of 2,6-dioxaspiro [4,5] decane derivatives and applications thereof in preparation of opiate receptor p agonist related drugs; and in particular relates to the derivative compounds shown in formula (I), tautomers thereof or pharmaceutically acceptable compositions thereof.

Abstract: Disclosed are a sustained release suspension containing dezocine analogue ester and a preparation method therefor. According to the present invention, an injectable oily auxiliary material which may pharmaceutically serve as a sustained-release depot and an excipient are selected, and micronization technology is used jointly with high pressure homogenization technology and an anti-solvent technique to prepare an injectable long-acting suspension. The main components of the suspension are a compound represented by formula (I), the injectable oil, and the like.

Abstract: The present invention relates to a compound shown in formula (II) or a pharmaceutically acceptable salt thereof and an application of the same in preparing a drug for treating a disease related to angiotensin II receptor type 2 (AT2R).

Abstract: A lifting container power generating device using a flexible guidance system includes a power source section, a power transmission section and an electrical section. The power source section includes a slide recess base electrically connected to a top portion of a flexible lifting container. A body is connected to the slide recess base through a linear bearing. A fixed roller and a sliding roller on the body are symmetrically disposed at two sides of a guide wire rope. Under the combined action of a preloaded spring and a tension spring, the fixed roller and the sliding roller jointly press tightly against the guide wire rope. The power transmission section includes an electromagnetic clutch axially connected to the fixed roller, and an electromagnetic clutch pulley connected to a power generator pulley via a V-belt. The power source section includes an electrical cabinet connected to the electromagnetic clutch, a power generator and a battery of the flexible lifting container.

Abstract: Disclosed in the present disclosure is a Dezocine analog, and particularly disclosed are compounds represented by formula (I), (II) and (III), a pharmaceutically acceptable salt or tautomer thereof.

Abstract: An intelligent charger with a diagnostic function and a charging method. The intelligent charger includes a control module, a diagnosis module, a charging module, a multi-path switch and a detection module. The control module is sequentially connected to the diagnosis module, the charging module and the multi-path switch; and the detection module is sequentially connected to an external connection terminal of a battery, the multi-path switch and the fault diagnosis module. The charging method includes a charging mode and a diagnosis mode; the diagnosis mode includes a two part function, namely fault diagnosis and lifetime detection; the fault diagnosis is detecting a fault problem which can occur in the battery and providing a prompt; and the lifetime detection is detecting the current capacity of a battery, and determining current battery life through the ratio of current capacity to rated capacity.

Abstract: Disclosed in the present disclosure is a Dezocine analogue, and particularly disclosed are compounds represented by formula (I), (II) and (III), a pharmaceutically acceptable salt or tautomer thereof.

Abstract: An intelligent charger with a diagnostic function and a charging method. The intelligent charger includes a control module, a diagnosis module, a charging module, a multi-path switch and a detection module. The control module is sequentially connected to the diagnosis module, the charging module and the multi-path switch; and the detection module is sequentially connected to an external connection terminal of a battery, the multi-path switch and the fault diagnosis module. The charging method includes a charging mode and a diagnosis mode; the diagnosis mode includes a two part function, namely fault diagnosis and lifetime detection; the fault diagnosis is detecting a fault problem which can occur in the battery and providing a prompt; and the lifetime detection is detecting the current capacity of a battery, and determining current battery life through the ratio of current capacity to rated capacity.

Abstract: Disclosed are various thermoelectric heaters. A thermal transfer component has a first plate attached to a second plate. A heating channel is formed by at least one of the first plate or the second plate of the thermal transfer component. The heating channel is between the first plate and the second plate of the thermal transfer component. A heating element is within the heating channel.